In-House Phage Amplification Assay Is a Sound Alternative for Detecting Rifampin-Resistant Mycobacterium tuberculosis in Low-Resource Settings
Open Access
- 1 January 2005
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (1) , 425-427
- https://doi.org/10.1128/aac.49.1.425-427.2005
Abstract
An in-house mycobacteriophage amplification assay for detecting rifampin-resistant Mycobacterium tuberculosis showed 100% sensitivity, 97.7% specificity, and 95.2% predictive value for resistance in a test of 129 isolates from a hot spot area of multidrug-resistant M. tuberculosis. The applicability of the test was demonstrated in the routine work flow of a low-resource reference laboratory.Keywords
This publication has 18 references indexed in Scilit:
- Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 2004
- Development of a Bacteriophage Phage Replication Assay for Diagnosis of Pulmonary TuberculosisJournal of Clinical Microbiology, 2004
- Multidrug-Resistant Tuberculosis in HIV-Negative Patients, Buenos Aires, ArgentinaEmerging Infectious Diseases, 2003
- Time to abandon the standard retreatment regimen with first-line drugs for failures of standard treatment.2003
- Utility of an In-House Mycobacteriophage-Based Assay for Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosis Clinical IsolatesJournal of Clinical Microbiology, 2003
- Evaluation of FASTPlaqueTB-RIF for determination of rifampicin resistance in Mycobacterium tuberculosis complex isolates.2003
- Tuberculosis Drug Resistance: A Global ThreatClinical Infectious Diseases, 2003
- Serum Cytokine Concentrations Do Not ParallelMycobacterium tuberculosis–Induced Cytokine Production in Patients with TuberculosisClinical Infectious Diseases, 2003
- A low cost, home-made, reverse-line blot hybridisation assay for rapid detection of rifampicin resistance in Mycobacterium tuberculosis.2002
- Standard Short-Course Chemotherapy for Drug-Resistant TuberculosisJAMA, 2000